TD ASSET MANAGEMENT INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$2,071,000
-17.5%
64,808
-10.6%
0.00%0.0%
Q1 2022$2,510,000
-18.0%
72,474
-30.7%
0.00%
-33.3%
Q4 2021$3,061,000
+71.5%
104,586
+49.3%
0.00%
+50.0%
Q3 2021$1,785,000
-6.8%
70,0740.0%0.00%0.0%
Q2 2021$1,915,000
-44.6%
70,074
-17.4%
0.00%
-50.0%
Q1 2021$3,458,000
-2.4%
84,856
+3.8%
0.00%0.0%
Q4 2020$3,542,000
-23.5%
81,786
-2.6%
0.00%
-33.3%
Q3 2020$4,632,000
-21.7%
84,011
-10.4%
0.01%
-25.0%
Q2 2020$5,917,000
+17.5%
93,728
-4.9%
0.01%
-11.1%
Q1 2020$5,037,000
-41.7%
98,582
-9.2%
0.01%
-30.8%
Q4 2019$8,635,000
+112.5%
108,629
+29.7%
0.01%
+116.7%
Q3 2019$4,063,000
+1.7%
83,729
+10.2%
0.01%0.0%
Q2 2019$3,997,000
+15.3%
75,991
+16.0%
0.01%
+20.0%
Q1 2019$3,467,000
+36.0%
65,495
+5.5%
0.01%
+25.0%
Q4 2018$2,549,000
+9.1%
62,095
+1.0%
0.00%
+33.3%
Q3 2018$2,336,000
+2.0%
61,461
+21.3%
0.00%0.0%
Q2 2018$2,290,000
-1.3%
50,661
+5.4%
0.00%
-25.0%
Q1 2018$2,321,000
+73.1%
48,061
+41.0%
0.00%
+100.0%
Q4 2017$1,341,00034,0750.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders